pharmaceutical stability process, environmental chambers, stability protocols, biotech
Source: Pharmaceutical Stability Discussion Group
The Pharmaceutical Stability Discussion Group is a non-profit professional affinity organization which meets periodically to share information about the pharmaceutical stability process. Participants must be currently employed by a pharmaceutical company or contract firm with an active on-site operation including environmental chambers and stability protocols. Consultants may not participate in the meetings.
PSDG is a branch of PDG (Pharmaceutical Discussion Groups) and is divided into three divisions; R&D, Manufactured Products, and Biotech. There are over 525 participants representing more than 175 pharmaceutical companies. Meetings of up to fifty participants are held at sites of volunteer host companies.
PDG also schedules Quality Control Discussion Group meetings. QCDG meets to share information on activities, regulations, and practices related to the quality control process.